Answers are grounded in this paper and cite their sources.
Recurrent variceal bleeding is very frequent after variceal haemorrhage and pharmacological therapy is the first choice treatment. Recently, baseline and repeat measurements of hepatic venous pressure gradient (HVPG) have been considered necessary to optimally manage patients receiving pharmacological therapy so as to reduce the frequency of rebleeding. However, the clinical validity and applicability of monitoring for target HVPG reductions is not sufficiently proven and needs to be specifically evaluated in a prospective trial.
No takes yet. Share an insight, caveat, or question.
Ulrich Thalheimer (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: